The current guideline represents the 6th edition of the “Japanese Clinical Practice Guideline
for Diabetes” which has been revised every three years since its first appearance in 2004 to …

Observational, genetic, and experimental data indicate that triglyceride rich lipoproteins
(TRLs) likely participate causally in atherothrombosis. Yet, robust clinical trial evidence that …

Background Diabetic nephropathy (DN) is one of the most serious complications of diabetes
and the leading cause of end-stage chronic kidney disease. Currently, there are no effective …

Diabetic retinopathy is the most frequently occurring complication of diabetes mellitus and
remains a leading cause of vision loss globally. Its aetiology and pathology have been …

Chronic kidney disease (CKD) is a common comorbidity in patients with type 2 diabetes
mellitus (T2DM) and both conditions are increasing in prevalence. CKD is estimated to …

Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes”
has attempted to promote evidence-based, rational, efficient and standardized clinical …

Diabetic nephropathy is a significant cause of chronic kidney disease and end-stage renal
failure globally. Much research has been conducted in both basic science and clinical …

An elevated serum level of LDL cholesterol is a well-known risk factor for cardiovascular
disease (CVD), but the role of elevated triglyceride levels is debated. Controversies …

Diabetic retinopathy (DR) is the most frequent complication of diabetes. The main risk factors
are disease duration, a poor glycemic control, and the presence of hypertension. However …

Abstract Background and aims This European Atherosclerosis Society (EAS) Task Force
provides practical guidance for combination therapy for elevated low-density lipoprotein …